Header Logo

Amanda Marzo

TitleAssistant Professor
InstitutionRush University, Rush Medical College
DepartmentInternal Medicine, Division of Hematology/Oncology/Cell Therapy
AddressChicago IL 60612
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My Scopus ID is 7006029679.
    My NIH COMMONS name is AMARZO.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Goldufsky JW, Daniels P, Williams MD, Gupta K, Lyday B, Chen T, Singh G, Kaufman HL, Zloza A, Marzo AL. Attenuated Dengue virus PV001-DV induces oncolytic tumor cell death and potent immune responses. J Transl Med. 2023 07 19; 21(1):483. PMID: 37468934.
      Citations:    
    2. Jhawar SR, Wang SJ, Thandoni A, Bommareddy PK, Newman JH, Marzo AL, Kuzel TM, Gupta V, Reiser J, Daniels P, Schiff D, Mitchell D, LeBoeuf NR, Simmons C, Goyal S, Lasfar A, Guevara-Patino JA, Haffty BG, Kaufman HL, Silk AW, Zloza A. Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer. J Immunother Cancer. 2023 07; 11(7). PMID: 37433716.
      Citations:    
    3. Reyes AF, Goldusky J, Bhimalli P, Marzo AL, Schneider JR. Tracking fluorescently labeled IL-15 and anti-PD-1 in the tumor microenvironment and draining lymph nodes. J Immunol Methods. 2022 06; 505:113253. PMID: 35358495.
      Citations:    
    4. Gupta KH, Nowicki C, Giurini EF, Marzo AL, Zloza A. Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy. Vaccines (Basel). 2021 Dec 18; 9(12). PMID: 34960243.
      Citations:    
    5. Newman JH, Chesson CB, Herzog NL, Bommareddy PK, Aspromonte SM, Pepe R, Estupinian R, Aboelatta MM, Buddhadev S, Tarabichi S, Lee M, Li S, Medina DJ, Giurini EF, Gupta KH, Guevara-Aleman G, Rossi M, Nowicki C, Abed A, Goldufsky JW, Broucek JR, Redondo RE, Rotter D, Jhawar SR, Wang SJ, Kohlhapp FJ, Kaufman HL, Thomas PG, Gupta V, Kuzel TM, Reiser J, Paras J, Kane MP, Singer EA, Malhotra J, Denzin LK, Sant'Angelo DB, Rabson AB, Lee LY, Lasfar A, Langenfeld J, Schenkel JM, Fidler MJ, Ruiz ES, Marzo AL, Rudra JS, Silk AW, Zloza A. Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer. Proc Natl Acad Sci U S A. 2020 01 14; 117(2):1119-1128. PMID: 31888983.
      Citations:    
    6. Sowell RT, Goldufsky JW, Rogozinska M, Quiles Z, Cao Y, Castillo EF, Finnegan A, Marzo AL. IL-15 Complexes Induce Migration of Resting Memory CD8 T Cells into Mucosal Tissues. J Immunol. 2017 10 01; 199(7):2536-2546. PMID: 28814601.
      Citations:    
    7. Kohlhapp FJ, Huelsmann EJ, Lacek AT, Schenkel JM, Lusciks J, Broucek JR, Goldufsky JW, Hughes T, Zayas JP, Dolubizno H, Sowell RT, K?hner R, Burd S, Kubasiak JC, Nabatiyan A, Marshall S, Bommareddy PK, Li S, Newman JH, Monken CE, Shafikhani SH, Marzo AL, Guevara-Patino JA, Lasfar A, Thomas PG, Lattime EC, Kaufman HL, Zloza A. Non-oncogenic Acute Viral Infections Disrupt Anti-cancer Responses and Lead to Accelerated Cancer-Specific Host Death. Cell Rep. 2016 10 18; 17(4):957-965. PMID: 27760326.
      Citations:    
    8. Sowell RT, Marzo AL. Resident-Memory CD8 T Cells and mTOR: Generation, Protection, and Clinical Importance. Front Immunol. 2015; 6:38. PMID: 25699054.
      Citations:    
    9. Sowell RT, Rogozinska M, Nelson CE, Vezys V, Marzo AL. Cutting edge: generation of effector cells that localize to mucosal tissues and form resident memory CD8 T cells is controlled by mTOR. J Immunol. 2014 Sep 01; 193(5):2067-71. PMID: 25070853.
      Citations:    
    10. Masopust D, Vezys V, Marzo AL, Lefran?ois L. Pillars article: preferential localization of effector memory cells in nonlymphoid tissue. Science. 2001. 291: 2413-2417. J Immunol. 2014 Feb 01; 192(3):845-9. PMID: 24443507.
      Citations:    
    11. Lerret NM, Marzo AL. Adoptive T-cell transfer combined with a single low dose of total body irradiation eradicates breast tumors. Oncoimmunology. 2013 Feb 01; 2(2):e22731. PMID: 23525138.
      Citations:    
    12. Lerret NM, Rogozinska M, Jaramillo A, Marzo AL. Adoptive transfer of Mammaglobin-A epitope specific CD8 T cells combined with a single low dose of total body irradiation eradicates breast tumors. PLoS One. 2012; 7(7):e41240. PMID: 22911764.
      Citations:    
    13. Zloza A, Kohlhapp FJ, Lyons GE, Schenkel JM, Moore TV, Lacek AT, O'Sullivan JA, Varanasi V, Williams JW, Jagoda MC, Bellavance EC, Marzo AL, Thomas PG, Zafirova B, Polic B, Al-Harthi L, Sperling AI, Guevara-Pati?o JA. NKG2D signaling on CD8? T cells represses T-bet and rescues CD4-unhelped CD8? T cell memory recall but not effector responses. Nat Med. 2012 Feb 26; 18(3):422-8. PMID: 22366950.
      Citations:    
    14. Moore TV, Clay BS, Ferreira CM, Williams JW, Rogozinska M, Cannon JL, Shilling RA, Marzo AL, Sperling AI. Protective effector memory CD4 T cells depend on ICOS for survival. PLoS One. 2011 Feb 18; 6(2):e16529. PMID: 21364749.
      Citations:    
    15. Marzo AL, Sowell RT, Scott B. The role of precursor frequency in the differentiation of memory T cells: memory by numbers. Adv Exp Med Biol. 2010; 684:69-78. PMID: 20795541.
      Citations:    
    16. Allam A, Conze DB, Giardino Torchia ML, Munitic I, Yagita H, Sowell RT, Marzo AL, Ashwell JD. The CD8+ memory T-cell state of readiness is actively maintained and reversible. Blood. 2009 Sep 03; 114(10):2121-30. PMID: 19617575.
      Citations:    
    17. Marzo AL, Yagita H, Lefran?ois L. Cutting edge: migration to nonlymphoid tissues results in functional conversion of central to effector memory CD8 T cells. J Immunol. 2007 Jul 01; 179(1):36-40. PMID: 17579018.
      Citations:    
    18. Graham VA, Marzo AL, Tough DF. A role for CD44 in T cell development and function during direct competition between CD44+ and CD44- cells. Eur J Immunol. 2007 Apr; 37(4):925-34. PMID: 17330818.
      Citations:    
    19. Moore MW, Cruz AR, LaVake CJ, Marzo AL, Eggers CH, Salazar JC, Radolf JD. Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune activation and induces gamma interferon production. Infect Immun. 2007 Apr; 75(4):2046-62. PMID: 17220323.
      Citations:    
    20. Klonowski KD, Marzo AL, Williams KJ, Lee SJ, Pham QM, Lefran?ois L. CD8 T cell recall responses are regulated by the tissue tropism of the memory cell and pathogen. J Immunol. 2006 Nov 15; 177(10):6738-46. PMID: 17082587.
      Citations:    
    21. Klonowski KD, Williams KJ, Marzo AL, Lefran?ois L. Cutting edge: IL-7-independent regulation of IL-7 receptor alpha expression and memory CD8 T cell development. J Immunol. 2006 Oct 01; 177(7):4247-51. PMID: 16982855.
      Citations:    
    22. Lefran?ois L, Marzo AL. The descent of memory T-cell subsets. Nat Rev Immunol. 2006 08; 6(8):618-23. PMID: 16868553.
      Citations:    
    23. Marzo AL, Klonowski KD, Le Bon A, Borrow P, Tough DF, Lefran?ois L. Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat Immunol. 2005 Aug; 6(8):793-9. PMID: 16025119.
      Citations:    
    24. Marzo AL, Vezys V, Klonowski KD, Lee SJ, Muralimohan G, Moore M, Tough DF, Lefran?ois L. Fully functional memory CD8 T cells in the absence of CD4 T cells. J Immunol. 2004 Jul 15; 173(2):969-75. PMID: 15240684.
      Citations:    
    25. Klonowski KD, Williams KJ, Marzo AL, Blair DA, Lingenheld EG, Lefran?ois L. Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity. 2004 May; 20(5):551-62. PMID: 15142524.
      Citations:    
    26. Masopust D, Vezys V, Usherwood EJ, Cauley LS, Olson S, Marzo AL, Ward RL, Woodland DL, Lefran?ois L. Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J Immunol. 2004 Apr 15; 172(8):4875-82. PMID: 15067066.
      Citations:    
    27. Lefran?ois L, Marzo A, Williams K. Sustained response initiation is required for T cell clonal expansion but not for effector or memory development in vivo. J Immunol. 2003 Sep 15; 171(6):2832-9. PMID: 12960304.
      Citations:    
    28. Nowak AK, Lake RA, Marzo AL, Scott B, Heath WR, Collins EJ, Frelinger JA, Robinson BW. Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells. J Immunol. 2003 May 15; 170(10):4905-13. PMID: 12734333.
      Citations:    
    Marzo's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (189)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _